Buy Veltam Plus 0.5+0.4 mg Capsules Online
Veltam Plus Capsules is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH).
- Dutasteride works by reducing the size of an enlarged prostate.
- Tamsulosin is known as an alpha blocker and works by relaxing the muscles of the bladder and prostate. This product helps to alleviate the symptoms of BPH, such as difficulty starting urine flow, weak jet and the need for frequent or urgent urination (including in the middle of the night). Dutasteride is not approved for the prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer.
Veltam Plus Capsules is a combination medication used to relieve symptoms of enlarged prostate (benign prostatic hyperplasia or BPH). Although it works well, it can cause problems with ejaculation, erection, and your sex drive.
- Brand: Veltam Plus 0.5+0.4 mg Capsules
- Composition: 0.5 mg Dutasteride + 0.4 mg Tamsulosin
- Dosage form: Capsules
- Treatment: Enlarged Prostate / Symptoms Of BPH
How do you take Veltam Plus Capsules?
The recommended dosage of Veltam Plus is 1 capsule (0.5 mg dutasteride and 0.4 mg tamsulosin hydrochloride) taken once daily approximately 30 minutes after the same meal each day. The capsules should be swallowed whole and not chewed or opened.
Veltam Plus Capsules is contraindicated for use:
Pregnancy
In animal reproduction and developmental toxicity studies, dutasteride inhibited the development of external genital organs in the fetus. Consequently, Veltam Plus Capsules can cause harm to the fetus when administered to a pregnant woman. If Veltam Plus Capsules is used during pregnancy or if the patient becomes pregnant while taking Veltam Plus Capsules, the patient should be informed of the potential danger to the fetus.
Women of childbearing potential
Pediatric patients
Patients with previously demonstrated clinically significant hypersensitivity (e.g., severe skin reactions, angioedema, urticaria, itching, respiratory symptoms) to dutasteride, other 5alpha reductase inhibitors, tamsulosin or any other component of Veltam Plus Capsules.
The FDA has approved the drug Jalyn for the treatment of benign prostatic hyperplasia
On June 14, 2010, the U.S. Food and Drug Administration (FDA) approved the drug Jalyn (dutasteride 0.5 mg and tamsulosin 0.4 mg) for the treatment of benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland.
Dutasteride is a 5α-reductase inhibitor, tamsulosin is an α1-adrenergic receptor blocker. The combination of these two drugs has been well studied and is the most effective treatment for BPH. The high efficiency and good tolerability of this combination have been proven. Dutasteride helps to reduce the prostate gland, and tamsulosin lowers the tone of the smooth muscles of the prostate gland, the neck of the bladder, the prostatic part of the urethra, facilitates the outflow of urine. At the same time, the symptoms of obstruction and irritation associated with benign prostatic hyperplasia decrease.
The drug is contraindicated in women and children, as well as in patients with hypersensitivity to dutasteride or tamsulosin.
